Dapivirine Vaginal Ring
Dapivirine Vaginal Ring is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population
Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women
Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women
Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Clinical Trials (6)
Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population
Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women
Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women
Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6